Haemonetics HAE Blood Center — Restructuring related costs
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Haemonetics in its filing.
Tagged under the XBRL concept hae:RestructuringRelatedCosts.
The official record: Haemonetics’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Haemonetics's blood center — restructuring related costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Haemonetics's blood center — restructuring related costs?
- Haemonetics (HAE) reported blood center — restructuring related costs of $0 in Q1 2026.
- How has Haemonetics's blood center — restructuring related costs changed year-over-year?
- Haemonetics's blood center — restructuring related costs decreased by 100.0% year-over-year, from $34K to $0.
- What is the long-term trend for Haemonetics's blood center — restructuring related costs?
- Over 4 years (2022 to 2026), Haemonetics's blood center — restructuring related costs has grown at a -79.4% compound annual growth rate (CAGR), from $556K to -$1K.
- What does blood center — restructuring related costs mean?
- Captures expenses directly associated with organizational restructuring initiatives within the Blood Center segment, such as severance, facility closures, or process realignments. Monitoring these costs provides insight into the company's efforts to optimize its cost structure and improve long-term segment profitability.